These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 8678696)
21. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder]. Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868 [TBL] [Abstract][Full Text] [Related]
22. A case report. A patient with idiopathic ventricular tachycardia. Venkata KI; Rahmat B; Kacharava G; Avaliani I Georgian Med News; 2008 Nov; (164):43-5. PubMed ID: 19075341 [TBL] [Abstract][Full Text] [Related]
23. Use of flecainide for refractory atrial tachycardia of pregnancy. Ahmed K; Issawi I; Peddireddy R Am J Crit Care; 1996 Jul; 5(4):306-8. PubMed ID: 8811156 [TBL] [Abstract][Full Text] [Related]
24. Intracoronary flecainide induces ST alternans and reentrant arrhythmia on intact canine heart: A role of 4-aminopyridine-sensitive current. Tachibana H; Yamaki M; Kubota I; Watanabe T; Yamauchi S; Tomoike H Circulation; 1999 Mar; 99(12):1637-43. PubMed ID: 10096943 [TBL] [Abstract][Full Text] [Related]
25. Transplacental flecainide therapy in the treatment of fetal supraventricular tachycardia. D'Souza D; MacKenzie WE; Martin WL J Obstet Gynaecol; 2002 May; 22(3):320-2. PubMed ID: 12521516 [No Abstract] [Full Text] [Related]
26. Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade. Padfield GJ; AlAhmari L; Lieve KV; AlAhmari T; Roston TM; Wilde AA; Krahn AD; Sanatani S Heart Rhythm; 2016 Feb; 13(2):609-13. PubMed ID: 26416620 [No Abstract] [Full Text] [Related]
27. Effects of magnesium on polymorphic ventricular tachycardias induced by aconitine. Adaniya H; Hayami H; Hiraoka M; Sawanobori T J Cardiovasc Pharmacol; 1994 Nov; 24(5):721-9. PubMed ID: 7532749 [TBL] [Abstract][Full Text] [Related]
28. [Propafenone and flecainide in the therapy of ventricular arrhythmias]. Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814 [TBL] [Abstract][Full Text] [Related]
29. [Exogenous adenosine as an anti-arrhythmia agent]. Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the in vivo hemodynamic effects of the antiarrhythmic agents vernakalant and flecainide in a rat hindlimb perfusion model. Allison B; Yang Y; Pourrier M; Gibson JK J Cardiovasc Pharmacol; 2011 Apr; 57(4):463-8. PubMed ID: 21283020 [TBL] [Abstract][Full Text] [Related]
31. Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction. Hashimoto H; Katoh H; Nakashima M J Pharmacobiodyn; 1992 May; 15(5):191-201. PubMed ID: 1527695 [TBL] [Abstract][Full Text] [Related]
32. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides. Gautam CS; Sharma PL; Pandhi P Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201 [TBL] [Abstract][Full Text] [Related]
39. [Effective dose of flecainide for arrhythmia in children]. Sumitomo N; Ushinohama H; Hara M; Otuka M; Harada K; Okuni M Kokyu To Junkan; 1993 Nov; 41(11):1079-82. PubMed ID: 8256048 [TBL] [Abstract][Full Text] [Related]
40. Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia. Biernacka EK; Hoffman P Europace; 2011 Jan; 13(1):129-30. PubMed ID: 20798117 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]